Vincerx Pharma, Inc.

Historical 13F Holders

Symbol
VINC
CUSIP
92731L106
All holders as of
Q4 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 92731L106 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Sage Rhino Capital, LLC 13G/A 0% 7/29/2025
Event 1/29/2025
Long Focus Capital Management, LLC 13G/A
0% 2/11/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 22 4.81 M $1.26 M
2024 Q3 28 11.0 M $7.89 M
2024 Q2 30 10.7 M $8.66 M
2024 Q1 41 8.50 M $42.9 M
2023 Q4 37 12.0 M $14.1 M
2023 Q3 35 10.7 M $10.8 M
2023 Q2 35 12.1 M $15.7 M
2023 Q1 36 12.8 M $13.3 M
2022 Q4 36 12.8 M $13.1 M
2022 Q3 44 14.5 M $20.0 M
2022 Q2 50 13.9 M $18.4 M
2022 Q1 67 16.3 M $65.1 M
2021 Q4 56 15.4 M $157 M
2021 Q3 56 15.4 M $249 M
2021 Q2 58 12.1 M $157 M
2021 Q1 39 9.16 M $177 M
2020 Q4 20 3.80 M $79.5 M